Accumulated data over the last century indicates that multiple sclerosis (MS) is the commonest disabling neurological disease of young adults in developed countries. Although the earliest attempts to establish the frequency ofMS involved the observation of the numbers of cases among hospital admissions with nervous diseases, in 1922 the study of the disease was taken a stage further by the reported distribution of MS in the United States based on diagnoses among army inductees in World War i. 1 The first attempt to establish properly MS prevalence by identifying the total number of cases within a defined population was performed in Switzerland in 1918-22 and reported in 1926 (prevalence: 36.4/100,000).2 The first such study in the British Isles was undertaken by an eminent Belfast neurologist, Sidney Allison, in Wales in 1929 (prevalence: 25.8/100,000). 3 Although several hundred epidemiological surveys of MS have been undertaken worldwide, the credit for the first recognition that MS exhibited an uneven distribution must go to Charcot, who in 1868 commented that "even today I do not believe that disseminated sclerosis is known in England" and in 1877 continued to observe that although the disease was prevalent in France, it was little recognised in Germany and uncommon in England.4'5 Although these observations are inapplicable today, other variations are now well established.
EVIDENCE FOR A LATITUDINAL GRADIENT?
The theory that the epidemiology of MS shows a latitudinal gradient in frequency probably originates from the demonstration in 1950 that MS death rates increased from south to north within North America.6 Subsequent studies gradually developed the picture of a higher prevalence in temperate than in subtropical and tropical zones, with a suggestion of a decline in rates again towards the poles. Some of the most elegant supportive studies have come from Australia, where the prevalence declines gradually from tropical Queensland (12/100,000) in the north to Tasmania (76/100,000) in the south.7 '8 Further evidence for geographic or environmental factors influencing the frequency ofMS has come from migration studies. In South Africa, MS prevalence in immigrants from the UK and other European countries is about 36/100,000 population.9 This rate is intermediate between those for the countries from which these people originated (50-100/100,000) and that for native born white South Africans (1 1/100,000). Further study ofEuropeans migrating to South Africa has also indicated that the risk of MS is related to the age of migration.10 In the group migrating before age 15, the number developing the disease was only one-third of the number expected from rates in the European population generally. (Table 1 ). Both the peak age specific prevalence rate and modal age of prevalent female cases are in the 35-44 year age group. For males the peak prevalence rates are in the 45-54 and 55-64 year age groups whilst the modal age group for prevalent males is 45-54 years. The homogeneity and stability of the population is emphasised by 90.9% of those with definite/ probable disease being born either within the study area (184 patients) or elsewhere in Northern Ireland (47 patients). This figure reaches 95.1% upon exclusion of those cases whose place of birth was not ascertained, with just nine cases (3.5%) born elsewhere in the British Isles and three (1.2%) born overseas. In those with definite or probable disease the mean interval between initial symptoms and diagnosis was 6.2 years. The mean duration of disease in definite/probable cases was 18.4 (range 0-52, SD 11.4) years. Using the technique of doubling the mean duration at prevalence day, the mean life expectancy was 36.8 years. 37 The distribution of Kurtzke EDSS scores is shown in the figure. The mean EDSS score was 4.9 and the median 5. 
